title: Best allogeneic transplantation approach for AML patients in first CR: is delayed unrelated donor bone marrow transplantation better than immediate unrelated cord blood transplantation?
authors: Department of Medicine, Division of Hematology, University and CHU of Liège, Liège, Belgium.|Giga-I3, Section of Hematology, University of Liège, Liège, Belgium.
authors: Frédéric
authors: F
authors: Baron
authors: Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.|EBMT Paris Office, Hospital Saint Antoine, Paris, France.|Université Pierre et Marie Curie, Paris, France.|Tel Aviv University (TAU), Tel Aviv, Israel.
authors: Arnon
authors: A
authors: Nagler
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D003131:Combined Modality Therapy; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D011788:Quality of Life; D012074:Remission Induction; D014184:Transplantation, Homologous; D016896:Treatment Outcome